Delivery Order SPE2DB20D2014-SPE2DB26FA21Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) with a ceiling value of $2,262.05. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $1,463.20. This is a firm fixed price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) valued at $2,843.25 on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,989.67 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) on October 20, 2025, with completion targeted for October 21, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) under a firm fixed-price contract with a ceiling value of $1,075.24. This non-set-aside competitive award is a child contract derived from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $5,030.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL). The contract is non-set-aside and competitively awarded, with performance scheduled for completion by August 13, 2025, at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) at a ceiling value of $3,835.96. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10 mL) with a ceiling value of $7,392.40. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,585.72 for the supply of Insulin Aspart 100 Unit/mL vials (10mL) under a firm fixed price contract. This non-set-aside award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.80 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Insulin Aspart 100 Unit/ml in 10ml vials. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by September 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA21YDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10 mL) valued at $4,652.81. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 30, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability to meet federal procurement requirements through competitive award processes across diverse therapeutic domains and contract values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 10/29/25 |